Davis Capital Management’s AbbVie ABBV Stock Holding History

Davis Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.4M	Buy	5,335 +33	+0.6%	+$8.46K	0.83%	32
2026 Q2	$1.33M	Sell	5,302 -24	-0.5%	-$5.16K	0.79%	36
2026 Q1	$1.16M	Sell	5,326 -22	-0.4%	-$4.88K	0.79%	39
2025 Q4	$1.22M	Sell	5,348 -28	-0.5%	-$6.38K	0.84%	36
2025 Q3	$1.24M	Buy	+5,376	New	+$1.09M	0.86%	37
2025 Q1	$1.13M	Sell	5,382 -109	-2%	-$21.2K	0.9%	34
2024 Q4	$976K	Sell	5,491 -119	-2%	-$21.9K	0.79%	38
2024 Q3	$1.11M	Sell	5,610 -75	-1%	-$14K	0.88%	37
2024 Q2	$969K	Sell	5,685 -41	-0.7%	-$6.79K	0.84%	37
2024 Q1	$1.04M	Sell	5,726 -88	-2%	-$15.2K	0.92%	39
2023 Q4	$901K	Buy	+5,814	New	+$848K	0.86%	40
2020 Q2	$702K	Sell	7,155 -152	-2%	-$13.4K	1.3%	31
2020 Q1	$557K	Buy	+7,307	New	+$622K	1.18%	35

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Davis Capital Management's ABBV Position: Q3 2026 in Review

Davis Capital Management increased its AbbVie (ABBV) stake by 0.62% in Q3 2026, buying an estimated $8.46K and bringing the position to 5,335 shares worth $1.4M. The position accounts for 0.83% of the portfolio, ranked #32.

Davis Capital Management first reported a position in ABBV in Q1 2020 and has held it in 13 quarters since. 1,551 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Davis Capital Management held 5,335 shares of AbbVie worth $1.4M as of Q3 2026.
Davis Capital Management bought 33 AbbVie shares in Q3 2026, an estimated $8.46K.
AbbVie made up 0.83% of Davis Capital Management's portfolio in Q3 2026, its #32 holding.
Davis Capital Management first reported a position in AbbVie in Q1 2020 and has held it in 13 quarters since.
1,551 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.